Assignee
BELLEROPHON THERAPEUTICS
US·0 granted patents·7 pending applications·0 citations·filing 2019–2021
Top patents by PatentIndex Score
7 records- 0153US2023067942A1IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENTBELLEROPHON THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0250US2023158064A1USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19BELLEROPHON THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0346US2023158260A1Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemiaBELLEROPHON THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0444US2021220586A1Method and apparatus for pulsatile delivery of nitric oxideBELLEROPHON THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0538US2022080147A1USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONSBELLEROPHON THERAPEUTICS·Filed 2020·Application pending·0 cites
- 0636US2022096535A1Combination drug therapies of pde-5 inhibitors and inhaled nitric oxideBELLEROPHON THERAPEUTICS·Filed 2020·Application pending·0 cites
- 0727US2023201497A1Method for pulsatile delivery of a gaseous drugBELLEROPHON THERAPEUTICS·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →